Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depot Formulation”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Testing effectiveness (Phase 2)Study completedNCT00913263
What this trial is testing

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

Who this might be right for
Prostate Cancer
Lidds AB 24
Large-scale testing (Phase 3)Study completedNCT00128531
What this trial is testing

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
GP-Pharm 120
Early research (Phase 1)Study completedNCT03715634
What this trial is testing

Study of a Novel Subcutaneous Depot Formulation of Buprenorphine

Who this might be right for
Opioid-use Disorder
Indivior Inc. 12
Not applicableStudy completedNCT00056654
What this trial is testing

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Abbott 164
Large-scale testing (Phase 3)Study completedNCT00667446
What this trial is testing

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Who this might be right for
PrecociousLeuprolide AcetateLuteinizing Hormone (LH)+9 more
AbbVie (prior sponsor, Abbott) 72
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Large-scale testing (Phase 3)Study completedNCT01567527
What this trial is testing

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 731
Large-scale testing (Phase 3)Study completedNCT00635817
What this trial is testing

Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Who this might be right for
Puberty, Precocious
Abbott 84
Testing effectiveness (Phase 2)Study completedNCT01348100
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 81
Large-scale testing (Phase 3)Study completedNCT00660010
What this trial is testing

Study of Lupron Depot In The Treatment of Central Precocious Puberty

Who this might be right for
Puberty, Precocious
Abbott 55
Large-scale testing (Phase 3)Ended earlyNCT00630799
What this trial is testing

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

Who this might be right for
Prostate Cancer
GP-Pharm 20
Early research (Phase 1)Study completedNCT02220712
What this trial is testing

Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 17
Early research (Phase 1)Study completedNCT03249740
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 32
Large-scale testing (Phase 3)Study completedNCT00731549
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,081
Testing effectiveness (Phase 2)Study completedNCT04085341
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Diabetic Macular EdemaRetina Vein Occlusion
Graybug Vision 21
Early research (Phase 1)Study completedNCT01870999
What this trial is testing

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 41
Large-scale testing (Phase 3)Study completedNCT00705783
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 843
Early research (Phase 1)Study completedNCT03287505
What this trial is testing

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 24
Very early researchStudy completedNCT04060043
What this trial is testing

Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
CMX Research 11
Large-scale testing (Phase 3)Study completedNCT00706654
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 937
Load More Results